Form 4: Zimmer Biomet Director Arthur J. Higgins Reports Acquisition of Phantom Stock Units

Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Summary

• Arthur J. Higgins, a director of Zimmer Biomet Holdings, Inc., reported a transaction involving phantom stock units.
• On March 31, 2024, Higgins acquired 207.156 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
• Following the reported transaction, Higgins beneficially owns 32,103.326 phantom stock units.
• This amount includes 60.334 phantom stock units accrued on January 31, 2024, under the dividend reinvestment provision of the plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction, which is neutral in sentiment.

Future Outlook

The phantom stock units will be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and holdings of company directors.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves phantom stock units granted to a director as part of their compensation.

Key Dates